ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2024, Vol. 33 ›› Issue (4): 327-332.DOI: 10.3969/j.issn.1006-298X.2024.04.005

• 论著 • 上一篇    下一篇

感染供者肾脏移植的安全性及术后感染的预后评估

  

  • 出版日期:2024-08-28 发布日期:2024-08-30

Assessment of the safety and prognosis of kidney transplantation from infected donors

  • Online:2024-08-28 Published:2024-08-30

摘要: 目的:评估感染供者肾脏用于移植的安全性及受者术后感染和预后情况。
方法:收集2014年8月至2021年4月遵义医科大学附属医院器官移植中心肾移植供者及其对应受者的临床数据。根据供者是否发生感染将其分为感染供者组(DI)和非感染供者组(DNI)。比较两组的并发症发生率和人/肾存活率以评估感染供者来源肾脏的安全性。再将所有纳入研究的受者根据其术后是否发生感染分为受者感染组(RI)和受者未感染组(RNI),并分析两组的预后情况。
结果:共收集83例供者数据,其中32例(38.55%)为感染供者。DI组与DNI组受者在术后并发症和6月的人/肾存活率方面差异无统计学意义。135受者中18例(13.33%)术后发生感染。RI组与RNI组在临床特征和6月时的预后无明显差异,但RI组的住院时间及抗生素使用时间增加,移植肾功能延迟恢复(DGF)和术区切口愈合延迟发生率较高(P<0.05)。
结论:感染供者肾脏用于移植具有良好的安全性,DI组和DNI组受者术后并发症发生率及近期人/肾存活率相似。术后发生感染的受者,DGF 与术区切口不愈合概率明显升高,其对远期人/肾存活情况的影响仍有待长期随访。


关键词: 肾移植, 感染供者, 受者, 安全性, 预后

Abstract: Objective:To evaluate the safety of using kidneys from infected donors for transplantation and the prognosis of recipients who develop postoperative infections.
Methodology:Clinical data from donors and their corresponding kidney transplant recipients at the organ transplantation center of Affiliated Hospital of Zunyi Medical University from August 2014 to April 2021 were collected. Recipients were first divided into two groups based on whether the donor had an infection: the infected donor group (DI) and the non-infected donor group (DNI). The complication rates and human/kidney survival rates of the two groups were compared to assess the safety of kidneys from infected donors. Subsequently, all recipients included in the study were divided into two groups based on whether they developed an infection postoperatively: the recipient infection group (RI) and the recipient non-infection group (RNI). The prognosis of these two groups was analyzed.
Results:A total of 83 donor data were collected, among which 32 cases (38.55%) were from infected donors. There was no statistical difference in the postoperative complication rates and human/kidney survival rates between the DI and DNI groups. There were no significant differences in overall clinical characteristics and prognosis between the RI group (18 cases) and the RNI group (117 cases), but the RI group had significantly higher incidences of delayed graft function (DGF) and surgical site wound non-healing, with statistical significance (P<0.05).
Conclusion:Kidneys from infected donors are safe for transplantation. Recipients who develop postoperative infections have a significantly higher incidence of DGF and surgical site wound non-healing compared to those without infections, but their overall prognosis shows no significant difference.


Key words: kidney transplantation, infected donor, recipientsafety, prognosis